nach oben

Erschienen in:

01.06.2013 | Original Article

Influence of heart rate at rest for predicting the metabolic syndrome in older Chinese adults

Erschienen in: Acta Diabetologica | Ausgabe 3/2013

Einloggen, um Zugang zu erhalten

Abstract

The aim of this study was to examine the relationship between seated resting heart rate and the metabolic syndrome (MetS) among older residents of Guangzhou, South China. A total of 30,519 older participants (≥50 years) from the Guangzhou Biobank Cohort Study were stratified into quartiles based on seated resting heart rate. The associations between each quartile and the MetS were assessed using multivariable logistic regression. A total of 6,907 (22.8 %) individuals were diagnosed as having the MetS, which was significantly associated with increasing heart rate quartiles (P < 0.001). Participants in the uppermost quartile (mean resting heart rate 91 ± 8 beats/min) of this cardiovascular proxy had an almost twofold increased adjusted risk (odds ratio (95 % CI) = 1.94 (1.79, 2.11), P < 0.001) for the MetS, as compared to those in the lowest quartile (mean resting heart rate, 63 ± 4 beats/min). Heart rate, which is an inexpensive and simple clinical measure, was independently associated with the MetS in older Chinese adults. We hope these observations will spur further studies to examine the usefulness of resting heart rate as a means of risk stratification in such populations, for which targeted interventions should be implemented.

Alberti KG, Zimmet P, Shaw J (2005) The metabolic syndrome–a new worldwide definition. Lancet 366:1059–1062PubMedCrossRef

Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120:1640–1645PubMedCrossRef

Kylin E (1923) Studien ueber das hypertonie-hyperglykämie-hyperurikä-miesyndrom. Zentralblatt fuer Innere Medizin 44:105–127

Ford ES (2004) The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study. Atherosclerosis 173:309–314PubMedCrossRef

Palatini P, Casiglia E, Pauletto P, Staessen J, Kaciroti N, Julius S (1997) Relationship of tachycardia with high blood pressure and metabolic abnormalities: a study with mixture analysis in three populations. Hypertension 30:1267–1273PubMedCrossRef

Palatini P, Julius S (1999) The physiological determinants and risk correlations of elevated heart rate. Am J Hypertens 12:3S–8SPubMedCrossRef

Rogowski O, Steinvil A, Berliner S, Cohen M, Saar N, Ben-Bassat OK et al (2009) Elevated resting heart rate is associated with the metabolic syndrome. Cardiovasc Diabetol 8:55PubMedCrossRef

Panzer C, Lauer MS, Brieke A, Blackstone E, Hoogwerf B (2002) Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study. Diabetes 51:803–807PubMedCrossRef

Gillum RF (1988) The epidemiology of resting heart rate in a national sample of men and women: associations with hypertension, coronary heart disease, blood pressure, and other cardiovascular risk factors. Am Heart J 116:163–174PubMedCrossRef

10.

Dyer AR, Persky V, Stamler J, Paul O, Shekelle RB, Berkson DM et al (1980) Heart rate as a prognostic factor for coronary heart disease and mortality: findings in three Chicago epidemiologic studies. Am J Epidemiol 112:736–749PubMed

11.

Kannel WB, Kannel C, Paffenbarger RS Jr, Cupples LA (1987) Heart rate and cardiovascular mortality: the Framingham study. Am Heart J 113:1489–1494PubMedCrossRef

12.

Gillum RF, Makuc DM, Feldman JJ (1991) Pulse rate, coronary heart disease, and death: the NHANES I epidemiologic follow-up study. Am Heart J 121:172–177PubMedCrossRef

13.

Gillman MW, Kannel WB, Belanger A, D’Agostino RB (1993) Influence of heart rate on mortality among persons with hypertension: the Framingham study. Am Heart J 125:1148–1154PubMedCrossRef

14.

Aronow WS, Ahn C, Mercando AD, Epstein S (1996) Association of average heart rate on 24-hour ambulatory electrocardiograms with incidence of new coronary events at 48-month follow-up in 1,311 patients (mean age 81 years) with heart disease and sinus rhythm. Am J Cardiol 78:1175–1176PubMed

15.

Palatini P, Casiglia E, Julius S, Pessina AC (1999) High heart rate: a risk factor for cardiovascular death in elderly men. Arch Intern Med 159:585–592PubMedCrossRef

16.

Cook S, Togni M, Schaub MC, Wenaweser P, Hess OM (2006) High heart rate: a cardiovascular risk factor? Eur Heart J 27:2387–2393PubMedCrossRef

17.

Tardif JC (2009) Heart rate as a treatable cardiovascular risk factor. Br Med Bull 90:71–84PubMedCrossRef

18.

Thomas GN, Schooling CM, McGhee SM, Ho SY, Cheung BM, Wat NM et al (2007) Metabolic syndrome increases all-cause and vascular mortality: the Hong Kong Cardiovascular Risk Factor study. Clin Endocrinol (Oxf) 66:666–671CrossRef

19.

O’Hartaigh B, Jiang CQ, Bosch JA, Zhang WS, Cheng KK, Lam TH et al (2011) Independent and combined associations of abdominal obesity and seated resting heart rate with type 2 diabetes among older Chinese: the Guangzhou Biobank Cohort study. Diabetes Metab Res Rev 27:298–306CrossRef

20.

O’Hartaigh B, Jiang CQ, Thomas GN, Tsvetanov KA, Bosch JA, Cheng KK et al (2011) Usefulness of physical fitness and the metabolic syndrome to predict vascular disease risk in older Chinese (from the Guangzhou Biobank Cohort Study-Cardiovascular Disease Subcohort [GBCS-CVD]). Am J Cardiol 108:845–850PubMedCrossRef

21.

Thomas GN, Jiang CQ, Lao XQ, McGhee SM, Zhang WS, Schooling CM et al (2006) Snoring and vascular risk factors and disease in a low-risk Chinese population: the Guangzhou Biobank Cohort study. Sleep 29:896–900PubMed

22.

Jiang C, Thomas GN, Lam TH, Schooling CM, Zhang W, Lao X et al (2006) Cohort profile: the Guangzhou Biobank Cohort study, a Guangzhou-Hong Kong-Birmingham collaboration. Int J Epidemiol 35:844–852PubMedCrossRef

23.

Deng HB, Macfarlane DJ, Thomas GN, Lao XQ, Jiang CQ, Cheng KK et al (2008) Reliability and validity of the IPAQ-Chinese: the Guangzhou Biobank Cohort study. Med Sci Sports Exerc 40:303–307PubMedCrossRef

24.

Ford ES, Giles WH, Dietz WH (2002) Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 287:356–359PubMedCrossRef

25.

Ford ES, Giles WH (2003) A comparison of the prevalence of the metabolic syndrome using two proposed definitions. Diabetes Care 26:575–581PubMedCrossRef

26.

Singh BN (2003) Increased heart rate as a risk factor for cardiovascular disease. Eur Heart J Suppl 5:G3–G9CrossRef

27.

Martin LJ, Comuzzie AG, Sonnenberg GE, Myklebust J, James R, Marks J et al (2004) Major quantitative trait locus for resting heart rate maps to a region on chromosome 4. Hypertension 43:1146–1151PubMedCrossRef

28.

Gianiorio FE, Casu M, Patrone V, Egan CG, Murialdo G (2011) Effect of pioglitazone on cardiac sympathovagal modulation in patients with type 2 diabetes. Acta Diabetol 48:283–290PubMedCrossRef

29.

Nerla R, Pitocco D, Zaccardi F, Scalone G, Coviello I, Mollo R et al (2011) Effect of pioglitazone on systemic inflammation is independent of metabolic control and cardiac autonomic function in patients with type 2 diabetes. Acta Diabetol 47:117–122CrossRef

30.

Poanta L, Porojan M, Dumitrascu DL (2011) Heart rate variability and diastolic dysfunction in patients with type 2 diabetes mellitus. Acta Diabetol 48:191–196PubMedCrossRef

31.

Julius S, Valentini M, Palatini P (2000) Overweight and hypertension: a 2-way street? Hypertension 35:807–813PubMedCrossRef

32.

Poirier P, Bogaty P, Philippon F, Garneau C, Fortin C, Dumesnil JG (2003) Preclinical diabetic cardiomyopathy: relation of left ventricular diastolic dysfunction to cardiac autonomic neuropathy in men with uncomplicated well-controlled type 2 diabetes. Metabolism 52:1056–1061PubMedCrossRef

33.

Narkiewicz K, Kato M, Phillips BG, Pesek CA, Choe I, Winnicki M et al (2001) Leptin interacts with heart rate but not sympathetic nerve traffic in healthy male subjects. J Hypertens 19:1089–1094PubMedCrossRef

34.

Soderberg S, Stegmayr B, Stenlund H, Sjostrom LG, Agren A, Johansson L et al (2004) Leptin, but not adiponectin, predicts stroke in males. J Intern Med 256:128–136PubMedCrossRef

35.

Soderberg S, Ahren B, Jansson JH, Johnson O, Hallmans G, Asplund K et al (1999) Leptin is associated with increased risk of myocardial infarction. J Intern Med 246:409–418PubMedCrossRef

36.

Hodis J, Gaier N, Farghali H (2009) Nitric oxide in patients with obesity and metabolic syndrome. Cas Lek Cesk 148:34–38PubMed

37.

Nisoli E, Clementi E, Carruba MO, Moncada S (2007) Defective mitochondrial biogenesis: a hallmark of the high cardiovascular risk in the metabolic syndrome? Circ Res 100:795–806PubMedCrossRef

38.

Ren J, Pulakat L, Whaley-Connell A, Sowers JR (2010) Mitochondrial biogenesis in the metabolic syndrome and cardiovascular disease. J Mol Med (Berl) 88:993–1001CrossRef

39.

Chowdhary S, Vaile JC, Fletcher J, Ross HF, Coote JH, Townend JN (2000) Nitric oxide and cardiac autonomic control in humans. Hypertension 36:264–269PubMedCrossRef

40.

Chowdhary S, Ng GA, Nuttall SL, Coote JH, Ross HF, Townend JN (2002) Nitric oxide and cardiac parasympathetic control in human heart failure. Clin Sci (Lond) 102:397–402CrossRef

41.

Gu D, Reynolds K, Duan X, Xin X, Chen J, Wu X et al (2003) Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: international collaborative study of cardiovascular disease in Asia (InterASIA). Diabetologia 46:1190–1198PubMedCrossRef

42.

Gu DF, Jiang H, Wu XG, Reynolds K, Gan WQ, Liu DH et al (2003) Prevalence, awareness, treatment and control of hypertension in Chinese adults. Zhonghua Yu Fang Yi Xue Za Zhi 37:84–89PubMed

Titel: Influence of heart rate at rest for predicting the metabolic syndrome in older Chinese adults
Publikationsdatum: 01.06.2013
Erschienen in: Acta Diabetologica / Ausgabe 3/2013
Print ISSN: 0940-5429
Elektronische ISSN: 1432-5233
DOI: https://doi.org/10.1007/s00592-012-0396-z

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

25.04.2024 Allergien und Intoleranzreaktionen Nachrichten

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2013

Total bilirubin is inversely associated with metabolic syndrome but not a risk factor for metabolic syndrome in Japanese men and women

Emergency hospitalizations for severe hypoglycaemia in patients with type 2 diabetes

Association between glucose variability as assessed by continuous glucose monitoring (CGM) and diabetic retinopathy in type 1 and type 2 diabetes

Effect of normalization of fasting glucose by intensified insulin therapy and influence of eNOS polymorphisms on the incidence of restenosis after peripheral angioplasty in patients with type 2 diabetes: a randomized, open-label clinical trial

Exercise might improve cardiovascular autonomic regulation in adolescents with type 1 diabetes